Report overview
This report aims to provide a comprehensive presentation of the global market for Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Diagnostics. This report contains market size and forecasts of Cancer Diagnostics in global, including the following market information:
Global Cancer Diagnostics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Diagnostics market was valued at US$ 164970 million in 2022 and is projected to reach US$ 230000 million by 2029, at a CAGR of 4.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Platform-based Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Diagnostics include Becton, Dickinson and Company, GE Healthcare, Abbott, Roche, Thermo Fisher Scientific, Agilent Technologies, Illumina, Siemens Healthcare and C.R. Bard, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Diagnostics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cancer Diagnostics Market Segment Percentages, by Type, 2022 (%)
Platform-based
Instrument-based
Global Cancer Diagnostics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cancer Diagnostics Market Segment Percentages, by Application, 2022 (%)
Breast Cancer
Lung Cancer
Colorectal Cancer
Others
Global Cancer Diagnostics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cancer Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Becton, Dickinson and Company
GE Healthcare
Abbott
Roche
Thermo Fisher Scientific
Agilent Technologies
Illumina
Siemens Healthcare
C.R. Bard
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Diagnostics, market overview.
Chapter 2: Global Cancer Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Cancer Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
